Alexia-Ileana Zaromytidou
Chief Editor
,
Nature Cancer
United Kingdom
I was born and raised in Greece and after finishing high school I moved to the UK for my undergraduate studies. I received my BSc in Molecular Biology from University College London and stayed in London to complete my PhD at the Cancer Research UK London Research Institute (CRUK LRI), which is now part of the Francis Crick Institute. I then moved to New York City to pursue my postdoctoral work at Memorial Sloan Kettering Cancer Center (MSKCC). After that, I joined the Nature Research journals as an associate editor. My scientific background is in molecular and cell biology, more specifically on signaling pathways such as MAPK, Rho and TGF-beta/BMP. These signaling cascades control gene expression programs that drive essential cellular functions, including cell proliferation or growth arrest, cell shape and motility and cell fate. When these pathways become deregulated they can lead to cancer. So I would say that cancer biology is my first true love, but my research interests have always been varied. During my years in the lab, I always read around topics and developed a great interest in stem cell biology, epigenetics and immunology that only increased during my years as an editor.
Sessions
-
Meet the Editors13-Oct-2026